Physician

Masoud Afshar, M.D.

According to 2025 Medicare claims, Masoud Afshar, M.D. (NPI: 1225287378) practices nephrology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is MASOUD AFSHAR MD INC (NPI: 1801484241; TIN: 854228829) and primary practice location at 92251-9998. Afshar is affiliated with the Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), participating under the MSSP model.

Afshar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 692 traditional Medicare patients, billed 9,601 HCPCS/CPT codes, and received $650,743 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,448 prescription claims across 644 beneficiaries totaling $1,691,849 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 85 claims. Open Payments data shows 80 records totaling $2,149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $414,722 to $650,743. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $535,087 to $1,691,849. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $834 to $171.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$338K$675K2015 Medicare payment: $414,722 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $491,917 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $446,235 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $564,113 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $550,331 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $482,912 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $372,112 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $592,469 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $675,382 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $650,743 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156816,186$414,722
20167224,399$491,917
20177814,257$446,235
20187105,470$564,113
20197666,130$550,331
20206933,907$482,912
20214282,682$372,112
20225166,436$592,469
20236088,967$675,382
20246929,601$650,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.3M2015 Drug cost: $535,087 (USD; Tot_Drug_Cst)2016 Drug cost: $645,359 (USD; Tot_Drug_Cst)2017 Drug cost: $903,994 (USD; Tot_Drug_Cst)2018 Drug cost: $1,427,005 (USD; Tot_Drug_Cst)2019 Drug cost: $1,752,332 (USD; Tot_Drug_Cst)2020 Drug cost: $2,317,998 (USD; Tot_Drug_Cst)2021 Drug cost: $1,503,397 (USD; Tot_Drug_Cst)2022 Drug cost: $1,462,157 (USD; Tot_Drug_Cst)2023 Drug cost: $1,661,007 (USD; Tot_Drug_Cst)2024 Drug cost: $1,691,849 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153834,186$535,087
20164104,897$645,359
20174965,943$903,994
20185717,124$1,427,005
20195746,617$1,752,332
20205416,913$2,317,998
20214624,256$1,503,397
20224835,222$1,462,157
20235436,450$1,661,007
20246447,448$1,691,849

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.7K$3.5K2016 Medicare payment: $1,725 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $3,464 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,826 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,055 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,088 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,753 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,417 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R42$1,725
2017N/R92$3,464
2018N/R77$1,826
2019N/R125$2,055
2020N/R77$2,088
2021N/RN/RN/R
2022N/R60$1,207
2023N/R78$1,753
2024N/R85$1,417

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more335755$89
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes170808$56
99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes2622,429$35
99454Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days167980$35
99458Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes2192,372$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VelphoroSucroferric Oxyhydroxide833,690$290,749
KerendiaFinerenone2287,560$155,629
FarxigaDapagliflozin Propanediol1778,010$136,696
LokelmaSodium Zirconium Cyclosilicate1786,888$135,989
TradjentaLinagliptin1846,758$107,263

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7517Mycophenolate mofetil, oral, 250 mgNN/R25$467
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R18$320
J7507Tacrolimus, immediate release, oral, 1 mgNN/R13$316
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R29$314

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.80$2,149AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Masoud Afshar, M.D.?

Tedicare shows public-source Medicare data for Masoud Afshar, M.D. (NPI 1225287378), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Masoud Afshar, M.D. have ACO affiliation data?

Masoud Afshar, M.D. is shown with ACO affiliation data for Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220).

What billing organization is linked to Masoud Afshar, M.D.?

Masoud Afshar, M.D. is linked to MASOUD AFSHAR MD INC (billing NPI 1801484241) in the available physician profile data.

Does Masoud Afshar, M.D. have Open Payments data?

Masoud Afshar, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.